Interleukin 17 enhances bone morphogenetic protein-2-induced ectopic bone formation
Abstract Interleukin 17 (IL-17) stimulates the osteogenic differentiation of progenitor cells in vitro through a synergy with bone morphogenetic protein (BMP)-2. This study investigates whether the diverse responses mediated by IL-17 in vivo also lead to enhanced BMP-2-induced bone formation. Since...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/738aad42290648b0a143de8cf1da883a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:738aad42290648b0a143de8cf1da883a |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:738aad42290648b0a143de8cf1da883a2021-12-02T16:08:13ZInterleukin 17 enhances bone morphogenetic protein-2-induced ectopic bone formation10.1038/s41598-018-25564-92045-2322https://doaj.org/article/738aad42290648b0a143de8cf1da883a2018-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-25564-9https://doaj.org/toc/2045-2322Abstract Interleukin 17 (IL-17) stimulates the osteogenic differentiation of progenitor cells in vitro through a synergy with bone morphogenetic protein (BMP)-2. This study investigates whether the diverse responses mediated by IL-17 in vivo also lead to enhanced BMP-2-induced bone formation. Since IL-17 is known to induce osteoclastogenesis, we studied the interactions between IL-17 and BMP-2 in ceramic scaffolds either or not carrying a coating with the bisphosphonate zoledronic acid (ZOL). Histological evaluation revealed that IL-17 alone did not induce any osteoclasts at day 10. On the other hand, BMP-2 clearly stimulated early tissue ingrowth and osteoclastogenesis. Both of these processes were blocked in presence of ZOL. IL-17 signaling restored early vascularized connective tissue formation and osteoclastogenesis induced by BMP-2 in ZOL-coated scaffolds. After 12 weeks, the bone volume induced by co-delivery of BMP-2 and IL-17 was doubled as compared to that induced by BMP-2 alone. We conclude that IL-17 has osteo-stimulatory effects through a synergy with bone-inductive BMP-2. Although local and single application of IL-17 does not mediate osteoclast formation, it could promote other processes involved in bone formation such as connective tissue ingrowth. The use of IL-17 may contribute to the development of improved bone graft substitutes.M. CroesM. C. KruytW. M. GroenK. M. A. van DorenmalenW. J. A. DhertF. C. ÖnerJ. AlblasNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-13 (2018) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q M. Croes M. C. Kruyt W. M. Groen K. M. A. van Dorenmalen W. J. A. Dhert F. C. Öner J. Alblas Interleukin 17 enhances bone morphogenetic protein-2-induced ectopic bone formation |
description |
Abstract Interleukin 17 (IL-17) stimulates the osteogenic differentiation of progenitor cells in vitro through a synergy with bone morphogenetic protein (BMP)-2. This study investigates whether the diverse responses mediated by IL-17 in vivo also lead to enhanced BMP-2-induced bone formation. Since IL-17 is known to induce osteoclastogenesis, we studied the interactions between IL-17 and BMP-2 in ceramic scaffolds either or not carrying a coating with the bisphosphonate zoledronic acid (ZOL). Histological evaluation revealed that IL-17 alone did not induce any osteoclasts at day 10. On the other hand, BMP-2 clearly stimulated early tissue ingrowth and osteoclastogenesis. Both of these processes were blocked in presence of ZOL. IL-17 signaling restored early vascularized connective tissue formation and osteoclastogenesis induced by BMP-2 in ZOL-coated scaffolds. After 12 weeks, the bone volume induced by co-delivery of BMP-2 and IL-17 was doubled as compared to that induced by BMP-2 alone. We conclude that IL-17 has osteo-stimulatory effects through a synergy with bone-inductive BMP-2. Although local and single application of IL-17 does not mediate osteoclast formation, it could promote other processes involved in bone formation such as connective tissue ingrowth. The use of IL-17 may contribute to the development of improved bone graft substitutes. |
format |
article |
author |
M. Croes M. C. Kruyt W. M. Groen K. M. A. van Dorenmalen W. J. A. Dhert F. C. Öner J. Alblas |
author_facet |
M. Croes M. C. Kruyt W. M. Groen K. M. A. van Dorenmalen W. J. A. Dhert F. C. Öner J. Alblas |
author_sort |
M. Croes |
title |
Interleukin 17 enhances bone morphogenetic protein-2-induced ectopic bone formation |
title_short |
Interleukin 17 enhances bone morphogenetic protein-2-induced ectopic bone formation |
title_full |
Interleukin 17 enhances bone morphogenetic protein-2-induced ectopic bone formation |
title_fullStr |
Interleukin 17 enhances bone morphogenetic protein-2-induced ectopic bone formation |
title_full_unstemmed |
Interleukin 17 enhances bone morphogenetic protein-2-induced ectopic bone formation |
title_sort |
interleukin 17 enhances bone morphogenetic protein-2-induced ectopic bone formation |
publisher |
Nature Portfolio |
publishDate |
2018 |
url |
https://doaj.org/article/738aad42290648b0a143de8cf1da883a |
work_keys_str_mv |
AT mcroes interleukin17enhancesbonemorphogeneticprotein2inducedectopicboneformation AT mckruyt interleukin17enhancesbonemorphogeneticprotein2inducedectopicboneformation AT wmgroen interleukin17enhancesbonemorphogeneticprotein2inducedectopicboneformation AT kmavandorenmalen interleukin17enhancesbonemorphogeneticprotein2inducedectopicboneformation AT wjadhert interleukin17enhancesbonemorphogeneticprotein2inducedectopicboneformation AT fconer interleukin17enhancesbonemorphogeneticprotein2inducedectopicboneformation AT jalblas interleukin17enhancesbonemorphogeneticprotein2inducedectopicboneformation |
_version_ |
1718384537139937280 |